Cigna Stock Issuance Proceeds increased by 128.0% to $57.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.4%, from $69.00M to $57.00M. Over 4 years (FY 2021 to FY 2025), Stock Issuance Proceeds shows a downward trend with a -11.2% CAGR.
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Standard for large-cap companies with significant equity-based compensation programs.
proceeds_from_stock_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $86.00M | $11.00M | $25.00M | $93.00M | $124.00M | $100.00M | $72.00M | $30.00M | $29.00M | $54.00M | $74.00M | $181.00M | $40.00M | $62.00M | $22.00M | $69.00M | $72.00M | $37.00M | $25.00M | $57.00M |
| QoQ Change | — | -87.2% | +127.3% | +272.0% | +33.3% | -19.4% | -28.0% | -58.3% | -3.3% | +86.2% | +37.0% | +144.6% | -77.9% | +55.0% | -64.5% | +213.6% | +4.3% | -48.6% | -32.4% | +128.0% |
| YoY Change | — | — | — | — | +44.2% | +809.1% | +188.0% | -67.7% | -76.6% | -46.0% | +2.8% | +503.3% | +37.9% | +14.8% | -70.3% | -61.9% | +80.0% | -40.3% | +13.6% | -17.4% |